ID
22968
Description
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00518882
Link
https://clinicaltrials.gov/show/NCT00518882
Keywords
Versions (1)
- 6/19/17 6/19/17 -
Uploaded on
June 19, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT00518882
Eligibility Diabetes NCT00518882
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
ID.5
Data type
boolean
Alias
- UMLS CUI [1]
- C0557978
Description
ID.6
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0935929
- UMLS CUI [1,2]
- C0025598
- UMLS CUI [1,3]
- C0038766
Description
ID.7
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0167117
- UMLS CUI [1,2]
- C1456408
Description
ID.8
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0232741
- UMLS CUI [1,2]
- C0232804
Description
ID.9
Data type
boolean
Alias
- UMLS CUI [1]
- C0741923
Description
ID.10
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0035309
- UMLS CUI [1,2]
- C0339471
Description
ID.11
Data type
boolean
Alias
- UMLS CUI [1]
- C0150254
Similar models
Eligibility Diabetes NCT00518882
- StudyEvent: Eligibility
C0025598 (UMLS CUI [1,2])
C0038766 (UMLS CUI [1,3])
C1456408 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,2])
C0339471 (UMLS CUI [1,2])